1 Min Read
Jan 2 (Reuters) - Sanuwave Health Inc:
* SANUWAVE RECEIVES FDA DE NOVO DECISION TO IMMEDIATELY MARKET THE DERMAPACE SYSTEM FOR THE TREATMENT OF DIABETIC FOOT ULCERS IN THE U.S. Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.